AMY WALLER: Open Payments
NPI 1255358875 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 55 payments from 11 companies in 2025. Trend: 2023 $1,582 · 2024 $1,808 · 2025 $1,061
Food & beverage: $984Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $300 |
| Janssen Biotech, Inc. | 7 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $177 |
| Regeneron Healthcare Solutions, Inc. | 6 | $149 |
| Madrigal Pharmaceuticals | 3 | $59 |
| Ardelyx, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Celltrion USA Inc. | 1 | $21 |
Products named: TREMFYA, DUPIXENT, LINZESS, ENTYVIO, RINVOQ, REZDIFFRA, EOHILIA, SKYRIZI.
Industry payments across MO — which companies pay providers there.
